NSMRX
Price
$34.16
Change
-$0.26 (-0.76%)
Updated
Aug 15 closing price
Net Assets
93.26M
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

NSMRX vs VSCPX

Header iconNSMRX vs VSCPX Comparison
Open Charts NSMRX vs VSCPXBanner chart's image
Nuveen Small/Mid-Cap Value I
Price$34.16
Change-$0.26 (-0.76%)
VolumeN/A
Net Assets93.26M
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
NSMRX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NSMRX vs. VSCPX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSMRX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. NSMRX (93.3M). VSCPX pays higher dividends than NSMRX: VSCPX (1.39) vs NSMRX (1.31). NSMRX was incepted earlier than VSCPX: NSMRX (19 years) vs VSCPX (15 years). NSMRX (1.17) is less costly to investors than VSCPX (0.03). NSMRX is a more actively managed with annual turnover of: 81.00 vs. VSCPX (13.00). NSMRX has a lower initial minimum investment than VSCPX: NSMRX (100000) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 9.18 vs. NSMRX (-1.14). NSMRX (58.37) and VSCPX (57.76) have equivalent 5 years return.
NSMRXVSCPXNSMRX / VSCPX
Total Expense Ratio1.060.033,533%
Annual Report Gross Expense Ratio1.170.033,900%
Fund Existence19 years15 years-
Gain YTD3.2962.528130%
Front LoadN/AN/A-
Min. Initial Investment1000001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets93.3M154B0%
Annual Yield % from dividends1.311.3994%
Returns for 1 year-1.149.18-12%
Returns for 3 years20.3220.5099%
Returns for 5 years58.3757.76101%
Returns for 10 years27.62113.1924%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune